ENDOR AG/ DE0005491666 /
24/05/2024 18:50:02 | Chg. 0.000 | Volume | Bid18:50:06 | Ask18:50:06 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.210EUR | 0.00% | 0 Turnover: 0.000 |
0.171Bid Size: 1,240 | 0.250Ask Size: 4,040 | 2.88 mill.EUR | - | 0.93 |
GlobeNewswire
28/03
CIO Leadership: Celebrating Charlie Feld and Other Recipients of HMG Strategy’s Global Leadership In...
GlobeNewswire
01/05/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
28/04/2020
Rigrodsky & Long, P.A. Files Class Action Suit Against Neon Therapeutics, Inc.
GlobeNewswire
24/04/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
17/04/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, MSBF, QUMU and SBBX Shareholders About Its Ongoing Inv...
GlobeNewswire
02/03/2020
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business ...
GlobeNewswire
16/01/2020
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
GlobeNewswire
16/01/2020
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies